GlassScriptPhysician profile
Reuben W Avila
NPI 1073621827
$14,665.40
in general payments reported to CMS, 2019-2025
63 companies · $1,513 in 2025
The $1,513 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $1,995 · 2021: $2,899 · 2022: $2,391 · 2023: $2,444 · 2024: $1,983 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,939.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,163.74 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,538.96 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,283.91 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,209.29 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Pfizer INC. | $918.28 | 2019-2025 | |
| Lilly USA, LLC | $748.77 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $640.62 | 2019-2024 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $453.11 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $427.67 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $401.69 | 2019-2024 | Belsomra, Verquvo, Steglatro |
| Astellas Pharma US INC | $397.02 | 2020-2024 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $350.39 | 2019-2024 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $299.93 | 2019-2024 | Ajovy |
| Biohaven Pharmaceutical Holding Company LTD. | $296.10 | 2022 | |
| Amarin Pharma, INC. | $248.63 | 2019-2022 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.88 | 2019-2025 | Jardiance, Ofev |
| Eisai INC. | $200.05 | 2020-2022 | |
| Abbott Laboratories | $196.30 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $187.89 | 2020-2021 | |
| Esperion Therapeutics, INC. | $136.19 | 2020-2025 | Nexletol |
| Allergan, INC. | $133.77 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $128.72 | 2022-2025 | Quviviq, Quviviq |
| Sanofi-Aventis U.S. LLC | $122.00 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $121.79 | 2021-2024 | Unithroid |
| Kowa Pharmaceuticals America, INC. | $111.68 | 2019-2023 | Livalo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.48 | 2024-2025 | Caplyta |
| Tris Pharma INC | $98.67 | 2022-2025 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $95.66 | 2019-2022 | |
| Corcept Therapeutics | $92.90 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $89.68 | 2021-2024 | |
| Radius Health, INC. | $80.50 | 2023-2025 | Tymlos |
| Corium, LLC | $63.56 | 2023-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $58.08 | 2023-2025 | Nuedexta, Rexulti |
| Boston Scientific Corporation | $57.88 | 2022-2025 | Watchman Flx |
| Sumitomo Pharma America, INC. | $57.19 | 2024-2025 | Gemtesa |
| Genentech USA, INC. | $56.61 | 2019-2020 | |
| Electromed, INC. | $51.72 | 2025 | Smartvest |
| Impel Pharmaceuticals INC. | $50.57 | 2023 | Trudhesa |
| Ultragenyx Pharmaceutical INC. | $49.24 | 2019-2024 | Dojolvi |
| Lundbeck LLC | $46.54 | 2024-2025 | Vyepti, Rexulti |
| Ironwood Pharmaceuticals, INC | $46.15 | 2020-2024 | |
| Phathom Pharmaceuticals, INC. | $44.80 | 2024 | Voquezna |
| Medicure Pharma INC. | $42.95 | 2022-2025 | Zypitamag |
| Bausch Health US, LLC | $40.00 | 2021-2022 | |
| Antares Pharma, INC. | $39.47 | 2019-2024 | Xyosted |
| Nevro Corp. | $38.35 | 2022-2023 | Senza |
| Collegium Pharmaceutical, INC. | $34.64 | 2025 | Jornay Pm |
| Dexcom, INC. | $33.34 | 2021-2023 | Dexcom G6 Transmitter |
| Pacira Therapeutics, INC. | $31.50 | 2019 | |
| Gilead Sciences, INC. | $30.71 | 2020 | |
| Exact Sciences Corporation | $30.41 | 2023-2025 | Cologuard Collection Kit |
| Celgene Corporation | $29.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.58 | 2019-2024 | |
| Ucb, INC. | $28.40 | 2019 | |
| Mylan Specialty L.P. | $20.02 | 2022 | |
| Inogen, INC. | $18.90 | 2023 | Inogen At Home Stationary Concentrator |
| Axsome Therapeutics, INC. | $18.73 | 2025 | Auvelity |
| Apria Healthcare LLC | $17.56 | 2021 | |
| Avanir Pharmaceuticals, INC. | $16.03 | 2022 | |
| Horizon Therapeutics Plc | $15.33 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.53 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.77 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reuben Avila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.